S Nagi Reddy 's Insider Trades & SAST Disclosures
S Nagi Reddy 's most recent trade in Concord Drugs Ltd. was a Disposal of 171,133 Warrants done at an average price of Rs. 24.8 . Disclosure was reported to the exchange on Oct. 30, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S Nagi Reddy 's has made SAST transactions in Concord Drugs Ltd. recently where a Acquisition of 342,266 shares done . Disclosure was reported to the exchange on Oct. 30, 2023.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | S Nagi Reddy & PACs | Promoter | Acquisition | 31 Oct 2023 | 342,266 | 5,540,649 (55.40%) | 3.52% | - | 27 Oct 2023 27 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Disposal | 30 Oct 2023 | 171,133 | 0 (0%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Acquisition | 30 Oct 2023 | 171,133 | 2,912,524 (29.12%) | 1.84% | 24.8 | 4,235,542 | 27 Oct 2023 27 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S Nagi Reddy & PACs | Promoter | Acquisition | 17 Oct 2023 | 342,264 | 5,198,383 (53.83%) | 3.54% | - | 12 Oct 2023 12 Oct 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Disposal | 14 Oct 2023 | 171,132 | 171,133 (0%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S.Nagi Reddy | Promoter & Director | Acquisition | 14 Oct 2023 | 171,132 | 2,741,391 (28.39%) | 1.84% | 24.8 | 4,235,517 | 12 Oct 2023 12 Oct 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Disposal | 29 Mar 2023 | 285,860 | 342,265 (0%) | 3.17% | 24.7 | 7,075,000 | 27 Mar 2023 27 Mar 2023 |
Insider Trading | Warrants | Conversion of security |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 29 Mar 2023 | 285,860 | 2,570,259 (28.46%) | 3.17% | 24.7 | 7,075,000 | 27 Mar 2023 27 Mar 2023 |
Insider Trading | Equity Shares | Conversion of security |
| Concord Drugs | S. Nagi Reddy & PAC | Promoter | Acquisition | 31 Mar 2023 | 285,860 | 2,570,259 (28.46%) | 3.16% | - | 27 Mar 2023 27 Mar 2023 |
SAST (29(2)) | - | Pref. Allotment | |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 09 Nov 2022 | 628,125 | 628,125 (0%) | 7.18% | 8.3 | 5,182,032 | 07 Nov 2022 07 Nov 2022 |
Insider Trading | Warrants | Preferential Offer |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 15 Nov 2021 | 397,500 | 2,284,399 (26.13%) | 4.55% | 0 | 0 | 15 Nov 2021 15 Nov 2021 |
Insider Trading | Equity Shares | Inter-se Transfer |
| Concord Drugs | S Nagi Reddy | Other | Acquisition | 15 Nov 2021 | 397,500 | - | 4.55% | - | 15 Nov 2021 15 Nov 2021 |
SAST (10(6)) | - | - | |
| Concord Drugs | S Nagi Reddy | Promoter | Acquisition | 16 Nov 2021 | 397,500 | 2,284,399 (26.13%) | 4.55% | - | 15 Nov 2021 15 Nov 2021 |
SAST (29(2)) | - | Inter-se Transfer | |
| Concord Drugs | S Nagi Reddy | Promoter | Acquisition | 05 Nov 2021 | 397,500 | - | 4.55% | - | 15 Nov 2021 15 Nov 2021 |
SAST (10(1)(a)) | - | None | |
| Concord Drugs | S Nagi Reddy | Promoter | Acquisition | 12 Oct 2021 | 397,500 | - | 4.55% | - | 22 Oct 2021 22 Oct 2021 |
SAST (10(1)(a)) | - | None | |
| Concord Drugs | S. Nagi Reddy | Promoter & Director | Acquisition | 24 Sep 2021 | 44,359 | 1,886,899 (21.58%) | 0.51% | 28.0 | 1,241,943 | 24 Aug 2021 24 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 25 Sep 2021 | 44,359 | 1,886,899 (21.58%) | 0.51% | - | 24 Aug 2021 24 Sep 2021 |
SAST (29(2)) | - | Market | |
| Concord Drugs | Nagi Reddy Seelam | Promoter & Director | Acquisition | 04 Mar 2021 | 84,145 | 1,842,540 (21.07%) | 0.96% | 25.0 | 2,103,295 | 02 Mar 2021 03 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 06 Mar 2021 | 84,145 | 1,842,540 (21.07%) | 0.96% | - | 02 Mar 2021 03 Mar 2021 |
SAST (29(2)) | - | Market | |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 02 Mar 2021 | 55,395 | 1,758,395 (20.11%) | 0.63% | 25.0 | 1,384,729 | 25 Feb 2021 01 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | Nagi Reddy Seelam | Promoter | Acquisition | 03 Mar 2021 | 55,395 | 1,758,395 (20.11%) | 0.63% | - | 25 Feb 2021 01 Mar 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.